BackReata Pharmaceuticals Overview
Reata Pharmaceuticals Inc - Class A

Reata Pharmaceuticals Target Price

Reata Pharmaceuticals target price — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Share Price

$172.36

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2022-11-28Goldman Sachs$11533.3% downsideOpen
2022-08-09Robert W. Baird$2784.3% downsideOpen
2022-08-08Goldman SachsMadhu Kumar$7655.9% downsideOpen
2022-05-27Citigroup$4673.3% downsideOpen
2022-05-24Goldman Sachs$7357.6% downsideOpen

Reata Pharmaceuticals (RETA) FAQ

Stockcircle tracks target price for Reata Pharmaceuticals (RETA), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Reata Pharmaceuticals's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main RETA overview so you can move from this figure to the surrounding analysis quickly.